These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 27777118)
1. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review. Non LR; Santos CA J Infect; 2017 Feb; 74(2):179-186. PubMed ID: 27777118 [TBL] [Abstract][Full Text] [Related]
2. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients. Liang M; Mansell C; Wade C; Fisher R; Devlin G N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes in adult patients with Staphylococcus lugdunensis bacteremia compared to patients with Staphylococcus epidermidis and Staphylococcus aureus bacteremia: a retrospective study in a 16-year period at the university hospital, Japan. Yukawa S; Noguchi T; Shinohara K; Tsuchido Y; Yamamoto M; Matsumura Y; Nagao M BMC Infect Dis; 2023 May; 23(1):269. PubMed ID: 37127589 [TBL] [Abstract][Full Text] [Related]
4. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747 [TBL] [Abstract][Full Text] [Related]
5. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis Bacteremia in children. Sato M; Kubota N; Horiuchi A; Kasai M; Minami K; Matsui H J Infect Chemother; 2016 May; 22(5):298-302. PubMed ID: 26898664 [TBL] [Abstract][Full Text] [Related]
6. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan. Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852 [TBL] [Abstract][Full Text] [Related]
7. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis. Sabe MA; Shrestha NK; Gordon S; Menon V Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):275-80. PubMed ID: 24523355 [TBL] [Abstract][Full Text] [Related]
9. Multicenter retrospective cohort study of the clinical significance of Staphylococcus lugdunensis isolated from a single blood culture set. Hauser N; Kim JJ; Luethy PM; Schmalzle SA; Bork JT Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115261. PubMed ID: 33290922 [TBL] [Abstract][Full Text] [Related]
10. Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia. Forsblom E; Högnäs E; Syrjänen J; Järvinen A PLoS One; 2021; 16(10):e0258511. PubMed ID: 34637480 [TBL] [Abstract][Full Text] [Related]
11. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM; Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. Liu PY; Huang YF; Tang CW; Chen YY; Hsieh KS; Ger LP; Chen YS; Liu YC J Microbiol Immunol Infect; 2010 Dec; 43(6):478-84. PubMed ID: 21195974 [TBL] [Abstract][Full Text] [Related]
13. Multicenter Study of the Clinical Presentation of Staphylococcus lugdunensis Bacteremia in Japan. Ainoda Y; Takeshita N; Hase R; Mikawa T; Hosokawa N; Kawamura I; Kurai H; Abe M; Kimura M; Araoka H; Fujita T; Totsuka K; Mezaki K; Sekiya N; Ohmagari N Jpn J Infect Dis; 2017 Jul; 70(4):405-407. PubMed ID: 28003590 [TBL] [Abstract][Full Text] [Related]
14. Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study. Aldman MH; Rasmussen M; Olaison L; Påhlman LI Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1103-1106. PubMed ID: 33378000 [TBL] [Abstract][Full Text] [Related]
15. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis. Ruggero MA; Peaper DR; Topal JE Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601 [TBL] [Abstract][Full Text] [Related]
18. Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study. Shrestha NK; Shah SY; Wang H; Hussain ST; Pettersson GB; Nowacki AS; Gordon SM Ann Thorac Surg; 2016 Jun; 101(6):2243-50. PubMed ID: 26872729 [TBL] [Abstract][Full Text] [Related]
19. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. Choi SH; Chung JW; Lee EJ; Kim TH; Lee MS; Kang JM; Song EH; Jun JB; Kim MN; Kim YS; Woo JH; Choi SH J Clin Microbiol; 2010 Sep; 48(9):3346-9. PubMed ID: 20592152 [TBL] [Abstract][Full Text] [Related]
20. Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin. Duhon B; Dallas S; Velasquez ST; Hand E Am J Health Syst Pharm; 2015 Jul; 72(13):1114-8. PubMed ID: 26092962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]